| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 10/05/2006 | WO2006105313A2 Compositions of and methods of using oversulfated glycosaminoglycans |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006104190A1 Par-2 agonist |
| 10/05/2006 | WO2006103275A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006103273A1 Substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006091796A3 Compositions and methods for diagnosing and treating retinal diseases |
| 10/05/2006 | WO2006014780A3 Methods and compositions for treating or preventing macular-degeneration related disorders |
| 10/05/2006 | US20060223881 Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 10/05/2006 | US20060223819 Quinoline Derivatives as NK-3 Antagonists |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | CA2603009A1 Treatment of eye disorders with sirtuin modulators |
| 10/05/2006 | CA2602574A1 Cytoskeletal active compounds, composition and use |
| 10/05/2006 | CA2601699A1 Substituted piperidines |
| 10/05/2006 | CA2601108A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/04/2006 | EP1707216A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 10/04/2006 | EP1707205A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 10/04/2006 | EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide |
| 10/04/2006 | EP1482936B1 Ophthalmic composition comprising ascomycin |
| 10/04/2006 | EP1409481B1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 10/04/2006 | EP1385840B1 Sulfonamides |
| 10/04/2006 | EP1206942B1 Water channel opener compositions and medicinal compositions for ophthalmic use |
| 10/04/2006 | CN1842594A Inhibition of apoptosis-specific elF-5A ('elF-5Al') with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics |
| 10/04/2006 | CN1840126A Chinese medicine for treating amblyopia and myopia |
| 10/04/2006 | CN1840093A Compound capsule with dendrobium stem and its preparing method |
| 10/04/2006 | CN1839993A Method for preparing houttuynia freeze-dried powder injection |
| 10/04/2006 | CN1839977A Chinese traditional medicine for treating nerve deafness and its preparation process |
| 10/04/2006 | CN1839904A Injection liquid containing glabrous sarcandra herb extract flavone effective part and its uses |
| 10/04/2006 | CN1839903A Pharmaceutical composition containing glabrous sarcandra herb extract and its uses |
| 10/04/2006 | CN1839902A Pharmaceutical composition containing glabrous sarcandra herb extract flavone effective part and its uses |
| 10/04/2006 | CN1839858A Ginsenoside F1 medicinal uses |
| 10/04/2006 | CN1839844A Gancilorvir eye ointment and its preparation |
| 10/04/2006 | CN1839840A Gatifloxacin eye drop and its preparing process |
| 10/04/2006 | CN1839834A Eye medicine for preventing and treating asthenopia and allergy |
| 10/04/2006 | CN1277822C Quinazoline derivatives, pharmaceutical composition containing the compound, their utilization and preparation method thereof |
| 10/04/2006 | CN1277542C Ganciclovir as ophthalmic medicine and its preparation method |
| 10/04/2006 | CN1277492C Food for promoting acuity of vision, improving pseudomyopia and relieving eye fatigue, and its process |
| 10/03/2006 | US7115780 For therapy of ulcers, pancreatitis, obesity, urinary incontinence and pollakiuria |
| 10/03/2006 | US7115777 For therapy of hypertension, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty |
| 10/03/2006 | US7115667 Protective film containing glycerides for interface between eyes and contact lenses |
| 10/03/2006 | US7115662 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 10/03/2006 | US7115635 Benzylpiperidine compound |
| 10/03/2006 | US7115629 Carbamates derived from arylalkylamines |
| 10/03/2006 | US7115623 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 10/03/2006 | US7115621 Chemical compounds |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115585 Compositions for treating epithelial and retinal tissue diseases |
| 10/03/2006 | US7115392 Polynucleotides encoding human vascular endothelial growth factor 2 |
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | US7115263 Compositions and methods for treating hyperimmune response in the eye |
| 10/03/2006 | US7115257 Delivering a growth factor to a host having a retinal degenerative disorder by administering an encapsulated ARPE-19 cell genetically engineered to secrete CNTF within a semipermeable membrane, especially by implantation |
| 09/28/2006 | WO2006102576A1 Water-dispersible carotenoids, including analogs and derivatives |
| 09/28/2006 | WO2006102333A2 Ophthalmic use of agents which inhibit connective tissue growth factor binding and signalling via the trka/p75ntr receptor complex |
| 09/28/2006 | WO2006101839A2 Enhanced bimatoprost ophthalmic solution |
| 09/28/2006 | WO2006101456A1 Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors |
| 09/28/2006 | WO2006067330B1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |
| 09/28/2006 | WO2005021776A3 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217378 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217276 Contact lens wetting solution |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216732 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound |
| 09/28/2006 | US20060216328 Topical composition comprising a cyclofructan, a carrier and a drug |
| 09/28/2006 | US20060216307 Vaccine composition |
| 09/28/2006 | US20060216301 Kdr peptides and vaccines containing the same |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | CA2611137A1 Water-dispersible carotenoids, including analogs and derivatives |
| 09/28/2006 | CA2602525A1 Drug delivery systems for treatment of diseases or conditions |
| 09/27/2006 | EP1704141A1 Prostaglandin nitrooxyderivatives |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1501826B1 Substituted indoles as alpha-1 agonists |
| 09/27/2006 | EP1395590B1 Dihydropyrrolo¬1,2-a|indole and tetrahydropyrido¬1,2-a|indole derivatives as prostaglandin d2 receptor antagonists |
| 09/27/2006 | EP1337521B1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 09/27/2006 | CN1838960A Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for local application |
| 09/27/2006 | CN1838955A Flupirtine preparation for treating neurodegenerative disorders of the visual system and diabetes mellitus |
| 09/27/2006 | CN1836705A Medicine for treating amblyopia and its preparing method |
| 09/27/2006 | CN1836670A Microsphere injection for treating ophthalmopathy |
| 09/27/2006 | CN1836667A Eye drop |
| 09/27/2006 | CN1836663A Tobramycin eye drops and its preparation method |
| 09/27/2006 | CN1276775C Chinese traditional medicine for treating optical fundus hemorrhage and its preparing process |
| 09/26/2006 | US7112607 Antihypoxic agents, antiischamic agents, antiarrhythmia agents |
| 09/26/2006 | US7112568 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 09/21/2006 | WO2006099353A1 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 09/21/2006 | WO2006099325A2 Methods of treating ear infections |
| 09/21/2006 | WO2006098292A1 Therapeutic agent for ophthalmic disease |
| 09/21/2006 | WO2006097625A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/21/2006 | WO2006097527A1 Use of acetyl-leucine for preparing a drug for treating balance disorders |
| 09/21/2006 | WO2006097458A1 Novel combination |
| 09/21/2006 | WO2006097337A2 11β-HYDROXYSTEROID DEHYDROGENASES |
| 09/21/2006 | WO2006097267A1 Vitamin mixtures |
| 09/21/2006 | WO2006047466A3 Ophthamological drugs |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211609 Novel agent for improving neurotransmission failure |
| 09/21/2006 | DE102006011111A1 Formulation for analgesic ear drops contains polyhydric alcohol, especially butan-1,3-diol or glycerol, dimethyl sulfoxide and optionally acid or buffer system and dexpanthenol |